Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis

Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis

Item
http://www.wikidata.org/entity/Q26825755
Clinical utility of array comparative genomic hybridisation in prenatal setting.Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases.Population-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy.Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities.Recurrent increased nuchal translucency: a first trimester presentation of familial 13p satellite deletion.Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.The added value of detailed early anomaly scan in fetuses with increased nuchal translucency.Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.Re: Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. I. Maya, S. Yacobson, S. Kahana, J. Yeshaya, T. Tenne, I. Agmon-Fishman, L. Cohen-Vig, M. Shohat, L. Basel-Vanagaite and R. Sharony. Ultrasound Obstet GynecoThe effect of progesterone use in the first trimester on fetal nuchal translucency.Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non-invasive cell-free DNA testing?ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis.Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada.
P2860

Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis

Item
http://www.wikidata.org/entity/Q26825755
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genomic microarray in fetuses ...... matic review and meta-analysis
@ast
Genomic microarray in fetuses ...... matic review and meta-analysis
@en
Genomic microarray in fetuses ...... matic review and meta-analysis
@nl
type
label
Genomic microarray in fetuses ...... matic review and meta-analysis
@ast
Genomic microarray in fetuses ...... matic review and meta-analysis
@en
Genomic microarray in fetuses ...... matic review and meta-analysis
@nl
prefLabel
Genomic microarray in fetuses ...... matic review and meta-analysis
@ast
Genomic microarray in fetuses ...... matic review and meta-analysis
@en
Genomic microarray in fetuses ...... matic review and meta-analysis
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Genomic microarray in fetuses ...... matic review and meta-analysis
@en
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921